Fantuzzi F., Del Giglio M., Gisondi P., Girolomoni G. Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis. Expert Opin Ther Targets. 2008;12(9):1085–1096. https://doi.org/10.1517/14728222.12.9.1085..
DOI: 10.1517/14728222.12.9.1085
Yamamoto T. Angiogenic and inflammatory properties of psoriatic arthritis. ISRN Dermatol. 2013:630620. https://doi.org/10.1155/2013/630620..
DOI: 10.1155/2013/630620
Marinoni B., Ceribelli A., Massarotti M.S., Selmi C. The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications. Auto Immun Highlights. 2014;5(1):9–19. https://doi.org/10.1007/s13317-013-0057-4..
DOI: 10.1007/s13317-013-0057-4
Соболев В.В., Денисова Е.В., Чебышева С.Н., Геппе Н.А., Корсунская И.М. Экспрессия гена IL-6 как маркер патологического состояния при псориазе и псориатическом артрите. Бюллетень экспериментальной биологии и медицины. 2022;173(1):92–95. https://doi.org/10.47056/0365-9615-2022-173-1-92-95..
DOI: 10.47056/0365-9615-2022-173-1-92-95
Соболев В.В., Денисова Е.В., Чебышева С.Н., Геппе Н.А., Корсунская И.М. Экспрессия гена IL-6 как маркер патологического состояния при псориазе и псориатическом артрите. Бюллетень экспериментальной биологии и медицины. 2022;173(1):92–95. https://doi.org/10.47056/0365-9615-2022-173-1-92-95..
DOI: 10.1007/s10517-022-05497-0
Sobolev V.V., Soboleva A.G., Denisova E.V., Pechatnikova E.A., Dvoryankova E., Korsunskaya I.M., Mezentsev A. Proteomic Studies of Psoriasis. Biomedicines. 2022;10(3):619. https://doi.org/10.3390/biomedicines10030619..
DOI: 10.3390/biomedicines10030619
Li J., Liu L., Rui W., Li X., Xuan D., Zheng S. et al. New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions. Dermatology. 2017;233(1):37–46. https://doi.org/10.1159/000471798..
DOI: 10.1159/000471798
Przepiera-Będzak H., Fischer K., Brzosko M. Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome. Int J Mol Sci. 2016;17(8):1255. https://doi.org/10.3390/ijms17081255..
DOI: 10.3390/ijms17081255
Johansen C., Usher P.A., Kjellerup R.B., Lundsgaard D., Iversen L., Kragballe K. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 2009;160(2):319–324. https://doi.org/10.1111/j.1365-2133.2008.08902.x..
DOI: 10.1111/j.1365-2133.2008.08902.x
Соболев В.В., Денисова Е.В., Корсунская И.М. Изменение экспрессии гена STAT3 при лечении псориаза. Медицинский совет. 2020;(12):71–74. https://doi.org/10.21518/2079-701X-2020-12-71-74..
DOI: 10.21518/2079-701X-2020-12-71-74
Sobolev V., Nesterova A., Soboleva A., Mezentsev A., Dvoriankova E., Piruzyan A. et al. Analysis of PPARγ Signaling Activity in Psoriasis. Int J Mol Sci. 2021;22(16):8603. https://doi.org/10.3390/ijms22168603..
DOI: 10.3390/ijms22168603
Sobolev V., Nesterova A., Soboleva A., Dvoriankova E., Piruzyan A., Mildzikhova D. et al. The Model of PPARγ-Downregulated Signaling in Psoriasis. PPAR Res. 2020:6529057. https://doi.org/10.1155/2020/6529057..
DOI: 10.1155/2020/6529057
Соболев В.В., Соболева А.Г., Потекаев Н.Н., Мельниченко О.О., Корсунская И.М., Артемьева С.И. Анализ экспрессии гена PPARγ при лечении псориаза. Медицинский совет. 2021;(8):82–87. https://doi.org/10.21518/2079-701X-2021-8-82-87..
DOI: 10.21518/2079-701X-2021-8-82-87
Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445(7128):648–651. https://doi.org/10.1038/nature05505..
DOI: 10.1038/nature05505
Sobolev V., Sakaniya L., Tretiakov A., Kokaeva Z., Naumova E., Rudko O. et al. Association of GA genotype of SNP rs4680 in COMT gene with psoriasis. Arch Dermatol Res. 2019;311(4):309–315. https://doi.org/10.1007/s00403-019-01904-1..
DOI: 10.1007/s00403-019-01904-1
Mussi A., Bonifati C., Carducci M., D’Agosto G., Pimpinelli F., D’Urso D. et al. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents. 1997;11(3):115–118. Available at: https://pubmed.ncbi.nlm.nih.gov/9498161/.https://pubmed.ncbi.nlm.nih.gov/9498161/
Mussi A., Bonifati C., Carducci M., D’Agosto G., Pimpinelli F., D’Urso D. et al. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents. 1997;11(3):115–118. Available at: https://pubmed.ncbi.nlm.nih.gov/9498161/.https://pubmed.ncbi.nlm.nih.gov/9498161/
Nesterova A.P., Klimov E.A., Zharkova M., Sozin S., Sobolev V., Ivanikova N.V. et al. Disease Pathways: An Atlas of Human Disease Signaling Pathways. Amsterdam, New York: Elsevier; 2019. 732 p. https://doi.org/10.1016/C2018-0-00586-1..
DOI: 10.1016/C2018-0-00586-1
Nesterova A.P., Klimov E.A., Zharkova M., Sozin S., Sobolev V., Ivanikova N.V. et al. Chapter 11 – Diseases of the skin and subcutaneous tissue. In: Nesterova A.P., Klimov E.A., Zharkova M., Sozin S., Sobolev V., Ivanikova N.V. et al. Disease Pathways: An Atlas of Human Disease Signaling Pathways. Amsterdam, New York: Elsevier; 2019, pp. 493–532. https://doi.org/10.1016/B978-0-12-817086-1.00011-7..
DOI: 10.1016/B978-0-12-817086-1.00011-7
Sobolev V.V., Mezentsev A.V., Ziganshin R.H., Soboleva A.G., Denieva M., Korsunskaya I.M., Svitich O.A. LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing. PLoS ONE. 2021;16(5):e0240956. https://doi.org/10.1371/journal.pone.0240956..
DOI: 10.1371/journal.pone.0240956
Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. https://doi.org/10.1006/meth.2001.1262..
DOI: 10.1006/meth.2001.1262
Akçali C., Guven E.H., Kirtak N., Inaloz H.S., Ozgoztasi O., Guvenc U. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis. J Int Med Res. 2014;42(5):1118–1122. https://doi.org/10.1177/0300060514539280..
DOI: 10.1177/0300060514539280
Elias A.N., Nanda V.S., Pandian R. Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene. BMC Dermatol. 2004;4:4. https://doi.org/10.1186/1471-5945-4-4..
DOI: 10.1186/1471-5945-4-4
Johansen C., Funding A.T., Otkjaer K., Kragballe K., Jensen U.B., Madsen M. et al. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol. 2006;176(3):1431–1438. https://doi.org/10.4049/jimmunol.176.3.1431..
DOI: 10.4049/jimmunol.176.3.1431